ELLA 2025: The Asset Base Jumped, but the Real Test Is Still at the Parent

Company Overview

ELLA is no longer a small story of stabilized assets, one land-development project in Even Yehuda, and a couple of hotels. 2025 turned it into a broader, more leveraged, more complex platform, mainly through the acquisition of two thirds of Sun Bat Yam and the entry of Mizrahi Tefahot Invest into both the equity and the convertible debt. A reader who focuses only on the higher equity base, higher NOI, and higher FFO could conclude that the company has already crossed into a cleaner phase. That is too generous.

What is working now is the existing asset base. The income-producing real-estate segment remains the core profit engine, Knafey HaEla remains fully occupied, consolidated operating cash flow rose to NIS 55.5 million, and net profit rose to NIS 49.1 million. Construction services at Kiryat Anavim and the “other” activities also expanded sharply. This is not a report of operational weakness.

The issue is that much of that improvement still sits below the parent or inside growth projects that continue to require funding, management attention, and execution. At the parent itself, the picture is far tighter: only NIS 13.6 million of cash at year-end, solo operating cash flow of NIS 1.8 million, and a gap that is still being bridged through equity, debt, and credit lines. So the key question around ELLA today is not whether value was created on the balance sheet. It is how much of that value is already accessible to the public entity and to bondholders.

There is also a practical screen that matters from the start. Since September 2022 only the bond series has been listed. This is not a liquid equity story that can quickly rerate. The correct lens is liquidity, covenants, funding access, and the quality of value that can actually move up to the parent.

An early economic map helps:

The second chart matters more than it may look at first glance. The State of Israel and Isrotel together accounted for 56.77% of company revenue in 2025. That is a quality anchor on one hand. On the other, it is still meaningful concentration, especially when part of the improvement in existing assets depends on those relationships staying strong.

Events and Triggers

Mizrahi improved the balance sheet and also raised the bar

First trigger: Mizrahi invested NIS 83.3 million for 10% of the company, received an option for up to another 3%, and also extended a NIS 16.7 million convertible loan for 6 years. This was not just an equity injection. It was also a stronger institutional signal to the credit market and to banks, together with tighter governance discipline.

But the move is not one-directional. Alongside the stronger equity base, the shareholders’ agreement gives Mizrahi consent rights over major decisions, points toward a 20% dividend policy, and pushes the company to try to list its shares within 4 years, with a one-year extension if needed. In other words, the company bought stronger capital but also took on a more institutional, more demanding framework.

Sun Bat Yam changed the size of the company and the nature of the story

Second trigger: In January 2025 ELLA completed the acquisition of two thirds of Sun Bat Yam. This is the asset that changed the balance sheet. The company entered a project with two 23-floor towers, commercial areas, an event hall, a gym, a spa, and parking, and ended the year with a book value of NIS 286.3 million for its share. It also recorded NIS 12.3 million of interim-use revenue and NIS 5.3 million of NOI.

That clearly enlarges the company, but it also changes the risk profile. Before Sun, ELLA was mainly a story of existing assets, limited land development, and established hotel assets. After Sun, it is far more exposed to completion, opening, operating-model decisions, lender conditions, and the conversion of a complicated project into a functioning property.

This is not theoretical. Ela Bat Yam committed up to NIS 130 million of initial shareholder funding to the partnership, and the construction work is being performed by a related company. The potential value remains within the broader group, but so do the execution burden and the capital-allocation burden.

Lincoln / Mekorot became less of an execution story and more of a cash story

Third trigger: The Mekorot transaction changed materially in July 2025. Instead of part of the consideration being delivered through planning and construction services, the deal moved to a full-cash route, taking total consideration to NIS 310 million plus linkage to the commercial construction-input index. The first NIS 71.8 million payment was already made in August 2025.

On the surface this looks cleaner. It reduces execution risk around building the new headquarters in Holon. In practice it also shifts the emphasis toward direct funding capacity. The company gave up some project complexity, but took on a more immediate cash obligation.

The post-balance-sheet credit line helps liquidity, but also reveals a need

Fourth trigger: After the balance-sheet date, Bank Hapoalim extended a NIS 48 million credit line to the company, at prime, through June 30, 2027. The covenants are comfortable: minimum equity of NIS 275 million and net financial debt to net CAP of up to 75%.

This is positive. But it should not be read as a pure upside signal. A line like this also tells you that the company is still building a liquidity layer at the parent. If parent cash were already comfortably wide, this filing would not have shown up now.

Efficiency, Profitability and Competition

The stable core is still income-producing real estate

The activity that holds the group together is still clear. Attributable segment profit from income-producing real estate rose to NIS 55.8 million from NIS 50.5 million, and Knafey HaEla remains the best asset in the portfolio. At the end of 2025 the asset stood at NIS 293.2 million of fair value, 100% occupancy, NIS 17.0 million of NOI, and NIS 23.5 million of revenue.

The more interesting question is why value rose. This was not just inflation or a mechanical revaluation. The valuation appendix explains that the increase also reflected facade work that strengthened retail income and better parking profitability, partly due to lower discounts to Ministry of Housing tenants. That is the real signal. The asset improved not only from the top down, but also through better operating economics inside the existing property.

Profitability improved, but the mix changed faster than the headline

On a consolidated basis, revenue rose to NIS 67.5 million from NIS 49.6 million, gross profit rose to NIS 35.9 million from NIS 28.1 million, and operating profit rose to NIS 65.6 million from NIS 53.3 million. FFO on management’s basis also rose to NIS 26.0 million from NIS 21.1 million.

But behind those numbers sits a sharp mix shift. Segment revenue from construction services rose to NIS 53.2 million from NIS 28.0 million, while “other” surged to NIS 55.5 million from NIS 10.8 million. A meaningful part of growth no longer comes from the old rent engine of stabilized assets alone. It now also comes from activities where execution, delivery, and completion matter just as much as balance-sheet value.

The chart highlights what is easy to miss on a first pass: hotels recovered in revenue, but contributed almost no profit. The real improvement came from income-producing real estate, construction services, and the new activity layers around Sun.

Hotels are operating again, but they still do not justify the tied-up capital

The hotel segment reported NIS 17.2 million of revenue in 2025 versus NIS 12.4 million in 2024. That looks encouraging. The problem is that segment profit fell to almost zero, just NIS 38 thousand. The board report explains that the shift in Bat Sheva’s operating model brought about roughly NIS 2.8 million of additional depreciation expense, which offset the improvement at Pablica.

That is a real gap between activity and economics. Pablica remains a branded asset with Isrotel management and a Marriott franchise, but the company also received, near the report date, a NIS 5.75 million demand from Issta Lines over its share of additional building rights, based on a NIS 69 million valuation. The company disputes the amount, but the demand is a reminder that future-value accounting does not equal cash.

Who is paying for the growth

This is the critical distinction. 2025 looks like a growth year, but much of that growth was financed by bank debt, fresh equity, a convertible loan, and project-level funding. That means this is not the same as “clean” organic growth. It bought the company scale, but it also expanded the inventory of projects, guarantees, partnerships, rates, and execution demands.

Cash Flow, Debt and Capital Structure

normalized / maintenance cash generation

If you look only at the cash-generating power of the existing platform, 2025 was a reasonable to good year. Consolidated cash flow from operations rose to NIS 55.5 million, above net profit of NIS 49.1 million. FFO also rose to NIS 26.0 million. That means the stabilized assets, the equity-accounted holdings, and part of the execution platform did generate real cash, not just revaluation gains.

Even here, though, the conclusion should not be pushed too far. FFO strips out revaluation and one-offs, but it still does not equal freely available parent cash. Part of the economics sits inside associates, part sits inside assets that still need investment, and part sits inside operating profits that do not automatically move up to the public parent.

all-in cash flexibility

Once you include actual cash uses, the picture becomes much tighter. On a consolidated basis, 2025 consumed NIS 293.0 million in investing activity, mainly because of Sun Bat Yam, investment property under construction, investment property spending, and advances on property investments. To fund that, the group relied on NIS 248.9 million from financing activity.

So after actual cash uses, 2025 was not a year of excess cash. It was a year of balance-sheet build-out through financing.

The gap is even clearer at the parent:

This is exactly where a superficial reading misses the point. The consolidated balance sheet grew to NIS 1.398 billion, equity rose to NIS 756.6 million, and covenants look wide. But accessible liquidity at the parent has not yet been solved.

Debt, covenants, and the calm that can be misleading

Loans and other borrowing from banks and others rose to NIS 263.8 million on the consolidated balance sheet, alongside NIS 178.5 million of bonds. The company is far from its main covenant boundaries: net financial debt to CAP of 36.19% versus a 75% ceiling, and equity of NIS 755 million versus a NIS 600 million threshold under the Mizrahi loan and NIS 275 million under the new Hapoalim line.

That is the supportive side. The other side is that covenant distance does not mean the company is free of funding pressure. The board report explicitly notes a working-capital deficit of NIS 68.7 million. The board says there are no warning signs, mainly because the company has access to banks and the capital markets. That is a fair argument, but it also reveals the mechanism: the gap is not closed purely by internal cash generation.

Sun Bat Yam has a front-loaded grace structure and a back-loaded test

The Bat Yam loans from Bank Hapoalim stand at NIS 223.7 million and another NIS 19.15 million at year-end. For 4 years, the structure is largely interest-only, with just 1.5% of principal due in year 4 before refinancing. That sounds comfortable, but the real test has merely been pushed forward.

Refinancing is conditioned on LTV below 75% and coverage above 1.2. At the same time, the bank’s waiver of repayment on the additional roughly NIS 18 million loan also depends on meeting the required conditions. In other words, the structure buys time, but it also makes 2026 and 2027 a very clear proof period: Sun must turn from an asset under completion into an operating asset with NOI that can support the next financing step.

Outlook

Finding one: 2026 will not be judged mainly by more balance-sheet growth. It will be judged by whether cash starts moving up to the parent.

Finding two: Sun Bat Yam is already large enough to change how the whole company is read, but still not mature enough to justify that new reading on its own.

Finding three: Lincoln / Mekorot became less execution-heavy, but more directly cash-intensive.

Finding four: Hotel activity recovered, but it still has not proved returns that justify the amount of tied-up capital.

Finding five: Covenants are not the active bottleneck right now. Liquidity, funding access, and the ability to upstream value are the real bottlenecks.

What kind of year this really is

2026 looks like a financed bridge year. It is not a reset year, because the operating base is not broken. It is also not a breakout year, because too much of the value case still depends on project completion, refinancing, and proof of accessible parent liquidity. This is a year in which the company needs to prove that the 2025 expansion was a justified intermediate step, not just a fast balance-sheet stretch.

What has to happen at Sun Bat Yam

The project needs to move from “asset under development with interim uses” to “operating asset.” That includes a final operating model, a commercial opening path, preserved occupancy in the commercial areas, and NOI that can eventually support refinancing. If that happens, 2025 will look like a smart expansion year. If it slips, 2025 will start to look like a year that bought volume at the expense of flexibility.

What has to happen at the parent

The parent needs to show that cash is not remaining trapped below it. By the end of 2025 it had relied on a NIS 76.3 million equity issuance, a NIS 19.0 million convertible loan, NIS 3.7 million from options, and then a NIS 48 million bank line after the balance-sheet date. That buys time, but it does not answer whether the asset base and subsidiaries can move cash upward on a stable basis.

What management can reasonably say in its favor

There is real evidence behind management’s claim that the group has funding access. The rating was reaffirmed in July 2025, covenant headroom is wide, some assets remain relatively unencumbered, and the company already proved it can bring in both institutional capital and bank funding. This is not a case of a closed market door.

The problem is that the market will not accept that argument indefinitely. Once a company expands this quickly, investors and lenders start asking whether dependence on outside funding is actually falling, or simply changing shape. At ELLA, by the end of 2025, it mostly changed shape.

Risks

Customer and asset concentration is still meaningful

The State of Israel accounted for 39.27% of company revenue in 2025, and Isrotel for another 17.5%. That gives the company strong anchors, but also leaves it meaningfully exposed to a small number of relationships. Knafey HaEla is a strong asset, but it also shows how much of the profit base still depends on a limited number of quality nodes rather than on broad diversification.

Dependence on the controlling shareholder is an explicit filing risk, not a footnote

The company explicitly says it has no dependency on any individual employee other than on Reuven Ela, who serves as both CEO and chairman. That matters. In a group that is growing through deals, partnerships, financing, and project execution, that is not a soft governance point. It is an execution risk.

The working-capital deficit did not trigger a warning sign, but it does demand discipline

The NIS 68.7 million working-capital deficit is not a distress signal by itself, because the company does not have persistent negative operating cash flow and it has proven access to outside funding. But it does mean the resilience case still depends on that access remaining open.

Sun Bat Yam adds partnership risk, financing risk, and opening risk

The project includes a one-third partner, excess-funding mechanics, bank control over cash usage, and restrictions on withdrawals without lender consent. This is not a standard stabilized real-estate asset. It is a structure in which management quality and execution discipline will determine how quickly theoretical value becomes accessible value.

The legal overhang is not trivial

The exposure is not large relative to the balance sheet, but it is cumulative: at Kiryat Anavim there is a roughly NIS 29 million claim, with the company’s project-related share at roughly NIS 10.5 million and, according to legal advisers, less than a 50% chance of success in its current form; there is also another early-stage claim from the Ashkenazi family; and at Pablica there is the NIS 5.75 million demand from Issta over additional rights. None of these is a thesis breaker on its own, but together they add management noise during a period that is already heavy on execution.

---

Conclusions

ELLA ends 2025 as a larger, more institutional, more diversified company, but not as a cleaner one. The asset base works, covenants are comfortable, and income-producing real estate still provides most of the stability. The main bottleneck remains the same, only in a bigger form: how much of that value actually moves up to the parent, and how quickly Sun Bat Yam turns from an execution-heavy asset into an operating asset that can be refinanced on sound terms.

Current thesis: 2025 proved that ELLA can grow, but it still did not prove that this growth has already translated into real parent-level flexibility.

What changed versus the older reading: the company is no longer just a set of income-producing assets and relatively small hotel exposures. Sun Bat Yam, Mizrahi, and the new institutional framework turned it into a broader platform, but also into a machine that needs more cash, more financing, and more proof.

Strongest counter-thesis: the concern may be overstated, because equity rose to NIS 756.6 million, net debt to CAP is only 36.19%, the rating was reaffirmed, and the company already proved that it can access both banks and institutional capital. That is a serious objection.

What could change the market reading in the near to medium term: any update showing a clean operating path at Sun Bat Yam, together with better parent cash or stronger upstreaming, would strengthen the positive case. Delays, more expensive financing, or continued dependence on external funding without matching operating proof would pull the focus back to liquidity quality.

Why this matters: the key question at ELLA is no longer whether there is value on the balance sheet. It is how much of that value is truly accessible, when, and at what funding cost.

What must happen over the next 2 to 4 quarters: Sun Bat Yam needs to move from development asset to operating asset with observable NOI, the parent needs to widen its cash layer without relying mainly on another capital raise, and the income-producing portfolio needs to keep holding revenue and NOI without quality erosion. What would weaken the thesis is the opposite: project delays, more funding without better operations, or a persistent gap between asset quality and parent liquidity.